Authors:
CAIROLI R
RIBERA S
NOSARI AM
MUTI G
MONTILLO M
SANTOLERI L
MORRA E
Citation: R. Cairoli et al., HIGH-DOSE ETOPOSIDE AND CYCLOPHOSPHAMIDE (HD-VP CTX) AS SALVAGE TREATMENT FOR ALL PATIENTS/, Blood, 90(10), 1997, pp. 3811-3811
Authors:
FOA P
IURLO A
ORAZI A
SAGLIO G
RIBERA S
BERTONI F
CALDIERA S
FORNIER M
MAIOLO AT
Citation: P. Foa et al., BIOLOGICAL DETERMINANTS OF LONG-TERM SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH CONVENTIONAL CHEMOTHERAPY, Acta haematologica, 97(3), 1997, pp. 187-188
Authors:
FOA P
IURLO A
RIBERA S
DAMILANO I
CALDIERA S
FORNIER M
BERTONI F
MAIOLO AT
Citation: P. Foa et al., CHRONIC MYELOID-LEUKEMIA TREATED WITH BUSULFAN - RELATIONSHIP BETWEENTOTAL AMOUNT OF DRUG REQUIRED DURING THE FIRST YEAR OF TREATMENT AND DURATION OF CHRONIC PHASE, Oncology Reports, 3(6), 1996, pp. 1067-1069
Authors:
FOA P
POMATI M
RIBERA S
CALDIERA S
BERTONI F
FORNIER M
MAIOLO AT
Citation: P. Foa et al., FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) FOR EVALUATING RESIDUAL DISEASE IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA DURING INTERFERON-ALPHA THERAPY, Oncology Reports, 3(5), 1996, pp. 847-849
Authors:
NERI A
FRACCHIOLLA NS
RADAELLI F
BOLETINI A
RIBERA S
MIGLIORINI C
TRECCA D
MAIOLO AT
Citation: A. Neri et al., P53 TUMOR-SUPPRESSOR GENE AND RAS ONCOGENES - MOLECULAR ANALYSIS IN THE CHRONIC AND LEUKEMIC PHASES OF ESSENTIAL THROMBOCYTHEMIA, British Journal of Haematology, 93(3), 1996, pp. 670-673